Aletti GD - Search Results

1

A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.

Aletti GD, Santillan A, Eisenhauer EL, Hu J, Aletti G, Podratz KC, Bristow RE, Chi DS, Cliby WA. Aletti GD, et al. Among authors: aletti g. Gynecol Oncol. 2007 Oct;107(1):99-106. doi: 10.1016/j.ygyno.2007.05.032. Epub 2007 Jun 28. Gynecol Oncol. 2007. PMID: 17602726

2

Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon.

Aletti GD, Gostout BS, Podratz KC, Cliby WA. Aletti GD, et al. Gynecol Oncol. 2006 Jan;100(1):33-7. doi: 10.1016/j.ygyno.2005.07.123. Epub 2005 Sep 8. Gynecol Oncol. 2006. PMID: 16153692

3

Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer.

Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Aletti GD, et al. Gynecol Oncol. 2006 Feb;100(2):283-7. doi: 10.1016/j.ygyno.2005.08.027. Epub 2005 Sep 22. Gynecol Oncol. 2006. PMID: 16182350

4

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.

Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA. Aletti GD, et al. Obstet Gynecol. 2006 Jan;107(1):77-85. doi: 10.1097/01.AOG.0000192407.04428.bb. Obstet Gynecol. 2006. PMID: 16394043 Free article.

5

Importance of surgical aggressiveness in advanced ovarian cancer.

Aletti GD, Cliby WA. Aletti GD, et al. J Clin Oncol. 2006 May 20;24(15):2397; author reply 2398-9. doi: 10.1200/JCO.2006.06.0111. J Clin Oncol. 2006. PMID: 16710044 No abstract available.

6

Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.

Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, Lee YK, Bible KC, Hartmann LC, Kaufmann SH, Shridhar V. Chien J, et al. J Clin Invest. 2006 Jul;116(7):1994-2004. doi: 10.1172/JCI27698. Epub 2006 Jun 8. J Clin Invest. 2006. PMID: 16767218 Free PMC article.

7

Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer.

Aletti GD, Podratz KC, Jones MB, Cliby WA. Aletti GD, et al. J Am Coll Surg. 2006 Oct;203(4):521-6. doi: 10.1016/j.jamcollsurg.2006.06.027. Epub 2006 Aug 23. J Am Coll Surg. 2006. PMID: 17000396

8

Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?

Aletti GD, Long HJ, Podratz KC, Cliby WA. Aletti GD, et al. Gynecol Oncol. 2007 Jan;104(1):212-6. doi: 10.1016/j.ygyno.2006.07.045. Epub 2006 Oct 4. Gynecol Oncol. 2007. PMID: 17023033

9

Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?

Cliby WA, Aletti GD, Wilson TO, Podratz KC. Cliby WA, et al. Among authors: aletti gd. Gynecol Oncol. 2006 Dec;103(3):797-801. doi: 10.1016/j.ygyno.2006.08.047. Epub 2006 Oct 18. Gynecol Oncol. 2006. PMID: 17052746

10

Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.

Aletti GD, Dowdy S, Podratz KC, Cliby WA. Aletti GD, et al. Am J Obstet Gynecol. 2006 Dec;195(6):1862-8. doi: 10.1016/j.ajog.2006.06.068. Am J Obstet Gynecol. 2006. PMID: 17132488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters